Dr. Sofia was responsible for the discovery and early development of sofosbuvir, which became the backbone of many hepatitis C curative therapies.Award-winning scientist Michael J. Sofia, PhD, who discovered the first reliably effective treatment for hepatitis C,
The Hepatitis B Foundation, Baruch S. Blumberg Institute and American Philosophical Society, joined together to celebrate the legacy—and the 100th birthday—of the late Baruch S. Blumberg, MD, DPhil, a Nobel Laureate, on July 29 in Philadelphia.More than
The Hepatitis B Foundation and Baruch S. Blumberg Institute recently presented Nicole E. Geracimos, MD, a Doylestown resident, with the organizations’ first Education Impact Award.Dr. Geracimos was honored at a June 26 event to raise funds for the
Eric J. Brand, a Doylestown-area resident, has been hired as the inaugural Chief People Officer for the Hepatitis B Foundation, Baruch S. Blumberg Institute, and Pennsylvania Biotechnology Center (PABC) after providing human resources support as a consultant
For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its
Lifesaving research by scientists, doctors and others around our country is being threatened by what’s happening currently in Washington, D.C., say officials of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC).“Medical research
The Baruch S. Blumberg Institute, presented the 2024 Lam Excellence in Medicinal Chemistry Award recently to Marianne Carlsen, senior scientist at Fox Chase Therapeutics Discovery, Inc. (FCTDI), located in Doylestown.(L-R) Dr. Ju-Tao Guo; Blumberg Institute; Dr. Allen
[caption id="attachment_19220" align="alignright" width="215"] Governor Kathy Hochul[/caption] New York State officials today announced the team that has been selected to build and launch BioGenesis, a cell and gene therapy center on Long Island, which will include a biotech
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Doylestown, Pa., Aug. 26, 2024 – When Timothy M. Block, PhD, an award-winning virologist and accomplished inventor, launched the
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been elected Chair of the Baruch S. Blumberg Institute’s Board of Directors.Located in Doylestown, the Blumberg Institute is a nonprofit organization established by the Hepatitis B
